Israel has made significant theoretical and
practical contributions to the biotechnology revolution and has
developed an advanced infrastructure of medical and paramedical research
as well as bioengineering capabilities. Biotechnology, biomedical, and
clinical research account for over half of all scientific publications.
The country’s industrial sector has increased its activities in the
medical field to capitalize on its extensive knowledge base.
Local scientists have developed methods for producing a human growth
hormone and interferon, a group of proteins effective against viral
infections. Copaxone, a medicine effective in the treatment of multiple
sclerosis, was developed in Israel - from basic research to industrial
production. Genetic engineering, has resulted in a wide range of
diagnostic kits based on monoclonal antibodies, along with other
Sophisticated medical equipment for both diagnostic and treatment
purposes has been developed and marketed worldwide, such as computer
tomography (CT) scanners, magnetic resonance imaging (MRI) systems,
ultrasound scanners, nuclear medical cameras, and surgical lasers. Other
innovations include a controlled-release liquid polymer to prevent
accumulation of tooth plaque, a device to reduce both benign and
malignant swellings of the prostate gland, the use of botulin to correct
eye squint, and a miniature camera encased in a swallowable capsule
used to diagnose gastro-intestinal disease.